» Authors » Charu Agarwal

Charu Agarwal

Explore the profile of Charu Agarwal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 348
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yadav A, Singh A, Madaan S, Pujani M, Raychaudhuri S, Agarwal C, et al.
Iran J Pathol . 2025 Mar; 19(4):400-407. PMID: 40034927
Background & Objective: Breast cancer is the leading cause of cancer deaths among women worldwide. Fine needle aspiration cytology (FNAC) and breast sonography have played a pivotal role in the...
2.
Arshad Z, Sharma P, Sharma S, Cheema M, Agarwal C, Tango T, et al.
Front Public Health . 2024 Dec; 12:1413556. PMID: 39678237
Background: X (Formerly known as Twitter) healthcare hashtags are a popular healthcare informatics and educational tool among medical professionals. #Globalhealth is one such widely used hashtag with extensive engagement. This...
3.
Pujani M, Raychaudhuri S, Singh K, Agarwal C, Jain M, Chauhan V, et al.
J Microsc Ultrastruct . 2024 Nov; 12(3):134-141. PMID: 39507640
Background: Intraoperative frozen section (IFS) plays a pivotal role in arriving at a diagnosis and guiding toward appropriate surgical management as there is a lack of effective ovarian cancer screening...
4.
Rajpoot J, Jain M, Pujani M, Agarwal C, Wadhwa R, Sarohi M
J Cancer Res Ther . 2024 Oct; 20(5):1650-1653. PMID: 39412940
Hepatocellular carcinoma (HCC) is much rarer in children and adolescents in comparison to adults with an incidence of 0.7/1,000,000 per year. Hepatitis B virus, a known carcinogen increases the chances...
5.
Agarwal C, Jain M, Rajpoot J, Jain S, Tyagi V, Abbas S, et al.
Indian J Surg Oncol . 2024 Mar; 15(1):121-124. PMID: 38511026
Proteinaceous lymphadenopathy (PLD) is a rare poorly defined, underrecognized entity of uncertain etiology, characterized by massive deposition of amorphous, acellular, eosinophilic, PAS-positive material within an enlarged lymph node. We report...
6.
Chatterjee K, Taneja J, Agarwal C, Sasidharan J, Das A, Pandey A
Indian J Med Microbiol . 2024 Mar; 48:100557. PMID: 38447858
An increasing number of fungal infections were reported post COVID-19 and many of them were caused by fungi of mixed aetiologies. This study was carried out to assess the utility...
7.
Verma L, Singh K, Pujani M, Jain M, Chandoke R, Agarwal C, et al.
Sultan Qaboos Univ Med J . 2024 Mar; 24(1):52-57. PMID: 38434449
Objectives: This study aimed to analyse the association of tumour budding (TB) and tumour-stroma ratio (TSR) with clinicopathological parameters that can be easily viewed on routine haematoxylin and eosin (H&E)-stained...
8.
Borra V, Borra N, Bondi G, Yartha S, Machineni N, Agarwal C, et al.
Curr Med Res Opin . 2024 Feb; 40(4):605-611. PMID: 38376123
Background: Inflammatory bowel disease (IBD) and dependent cannabis use or cannabis use disorder (CUD+) are independent risk factors for cardiovascular diseases. Usage of cannabis for pain increased in IBD patients....
9.
Menia R, Raychaudhuri S, Agarwal C, Taneja J
Indian J Pathol Microbiol . 2023 Dec; 66(4):823-828. PMID: 38084540
COVID-19 caused by SARS-CoV-2 has been studied and reported widely since November 2019, after its first case was detected in Wuhan, China. It has proven to be a fatal disease...
10.
Agarwal C, Jain M, Pujani M, Rajpoot J, Goel H, Sarohi M, et al.
Diagn Cytopathol . 2023 Oct; 52(1):E19-E22. PMID: 37786377
Secretory carcinoma (SC) was originally described as mammary analogue secretory carcinoma (MASC). We present here a case of 33 years old male who came to ENT outpatient department with a...